Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Luminari

Showing results (51-60 of 210) with videos related to

Pageof 21
Sort By:
Cancer|February 28, 2009
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphomaStefano Luminari, Luigi Marcheselli, Stefano Sacchi, et al.
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Haematologica|October 17, 2015
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana LinfomiStefano Luminari, Sara Galimberti, Annibale Versari, et al.
Cancer|March 31, 2007
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patientsStefano Sacchi, Samantha Pozzi, Luigi Marcheselli, et al.
Epidemiologia E Prevenzione|June 21, 2017
Survival of cancer patients in ItalyVincenzo Coviello, Carlotta Buzzoni, Mario Fusco, et al.
American Journal of Hematology|October 29, 2009
Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over timeSamantha Pozzi, Raffaella Marcheselli, Simona Falorio, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|October 6, 2020
New information flows for cancer registries: testing the use of laboratory data in the province of Reggio Emilia, ItalyFrancesca Roncaglia, Pamela Mancuso, Massimo Vicentini, et al.
Hematological Oncology|October 8, 2025
Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian PerspectiveGiacomo Loseto, Maria Chiara Tisi, Antonella Anastasia, et al.
Hematological Oncology|April 25, 2024
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experienceVittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, et al.
Annals of Hematology|April 18, 2013
Bendamustine salvage therapy for T cell neoplasmsFrancesco Zaja, Luca Baldini, Andrés J M Ferreri, et al.
Pageof 21

Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
Cancer|February 28, 2009
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphomaStefano Luminari, Luigi Marcheselli, Stefano Sacchi, et al.
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Haematologica|October 17, 2015
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana LinfomiStefano Luminari, Sara Galimberti, Annibale Versari, et al.
Cancer|March 31, 2007
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patientsStefano Sacchi, Samantha Pozzi, Luigi Marcheselli, et al.
Epidemiologia E Prevenzione|June 21, 2017
Survival of cancer patients in ItalyVincenzo Coviello, Carlotta Buzzoni, Mario Fusco, et al.
American Journal of Hematology|October 29, 2009
Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over timeSamantha Pozzi, Raffaella Marcheselli, Simona Falorio, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|October 6, 2020
New information flows for cancer registries: testing the use of laboratory data in the province of Reggio Emilia, ItalyFrancesca Roncaglia, Pamela Mancuso, Massimo Vicentini, et al.
Hematological Oncology|October 8, 2025
Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian PerspectiveGiacomo Loseto, Maria Chiara Tisi, Antonella Anastasia, et al.
Hematological Oncology|April 25, 2024
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experienceVittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, et al.
Annals of Hematology|April 18, 2013
Bendamustine salvage therapy for T cell neoplasmsFrancesco Zaja, Luca Baldini, Andrés J M Ferreri, et al.
Pageof 21